Bone marrow suppression after chemotherapy for gastric cancer
Conditions
Interventions
Sponsors
Changde First People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) The diagnosis of gastric cancer meets the diagnostic criteria of the 2022 NCCN guidelines; (2) The XELOX regimen has been evaluated as effective in anti-tumor therapy; (3) Age range from 18 to 75 years old; (4) KPS scoring function status score = 70 points; (5) The laboratory examination results and clinical pathological data before chemotherapy are complete, and the follow-up data after chemotherapy are complete.
Exclusion criteria
Exclusion criteria: (1) Merge primary tumors from other locations; (2) Merge bone marrow and blood related diseases; (3) Severe heart, lung, liver, and kidney diseases, etc; (4) Patients receiving prophylactic use of colony stimulating factor drugs before chemotherapy; (5) The patient did not sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| systemic immune-inflammation index,SII;neutrophilto lymphocyte ratio,NLR;plateletto lymphocyte ratio,PLR;prognostic nutritional index,PNI; | — |
Countries
China
Contacts
Public ContactKexia CHEN
Changde First People's Hospital
Outcome results
None listed